PDS Biotechnology Corporation (PDSB) — Dilution Risk Analysis

Current Snapshot

PDS Biotechnology Corporation (PDSB) has a DilutionWatch score of 77/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
55,971,338 Source
Public Float
54,404,075 Source
Float as % of Outstanding
97.2%

Dilution Risk Score

Score: 77/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 8-K 1, EFFECT 1, S-3/A 1, 4 7.

FormFiledAccession
8-K 2026-05-01 0001140361-26-018464
EFFECT 2026-04-28 9999999995-26-001350
S-3/A 2026-04-24 0001140361-26-016756
4 2026-03-03 0001140361-26-007639
4 2026-03-03 0001140361-26-007640
4 2026-03-03 0001140361-26-007641
4 2026-03-03 0001140361-26-007642
4 2026-03-03 0001140361-26-007643
4 2026-03-03 0001140361-26-007644
4 2026-03-03 0001140361-26-007645

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $200,000,000 Source
Cash runway 1 months Source
Three-year share count growth 79.93% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 77/10) Source
Cash Runway
1 months Source
Shelf Registration Capacity
$200,000,000 Source
Share Count Growth (3-Year)
79.93% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.